Skip to main
MDAI

MDAI Stock Forecast & Price Target

MDAI Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Spectral AI Inc is projected to experience substantial revenue growth, with expectations of reaching a compound annual growth rate (CAGR) of over 69% from FY26 through FY30 following the commercial launch of its DeepView System. The company's revenue expectations have notably been adjusted to $18.5 million for FY26, indicating a significant increase from prior estimates, reflecting a heightened confidence in its research and development efforts. Additionally, Spectral AI's license model is anticipated to foster recurring revenue at high margins, positioning the company for stable and predictive growth within the MedTech industry.

Bears say

Spectral AI Inc has revised its fiscal year 2025 revenue guidance significantly downward, projecting approximately $18.5 million in revenue, which represents a year-over-year decline of 37.6% compared to earlier estimates. This reduction in expected revenue is attributed to delays associated with the timing of work under the BARDA contract and the impacts of a government shutdown, leading to concerns about the company's operational efficiency. Additionally, a lack of specific revenue guidance for fiscal year 2026, coupled with anticipations of further declines due to extended clinical and regulatory development timelines, exacerbates the uncertainty surrounding the company's financial outlook.

MDAI has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Spectral AI Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Spectral AI Inc (MDAI) Forecast

Analysts have given MDAI a Strong Buy based on their latest research and market trends.

According to 1 analysts, MDAI has a Strong Buy consensus rating as of Apr 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $3, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $3, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Spectral AI Inc (MDAI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.